Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Missouri for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Missouri only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Missouri (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Harris Sultan (NPI 1669890570)

Field	Value
Entity Type	Individual
Organization	Harris Sultan
Address	517 S Euclid Ave
City	Saint Louis
State	MO
ZIP	63110
Taxonomy	Ophthalmology Physician
NPI Enumerated	March 29, 2014

Payer Source	Total Paid
Medicare	$3.3M
Medicaid	$0

Key Findings

This provider’s Medicare revenue is heavily driven by intravitreal drug administration: J0178 appears as the single largest line item with 2K claims generating $1.4M (43.1% of Medicare revenue), and additional anti-VEGF related codes such as J2778 (1.6K claims, $306.2K, 9.4%) and Q5128 (1.1K claims, $235.4K, 7.2%) further indicate that in‑office injectable therapies are the core service line. The presence of procedure code 67028 (1.8K claims, $188.7K, 5.8%) reinforces that isolated intravitreal injection procedures are a routine part of operations rather than occasional services.

The provider shows strong revenue concentration: the top three Medicare codes by revenue account for 60.4% of this provider's total Medicare revenue, within a total Medicare take of $3.3M. Notably, J0178 alone is responsible for 43.1% ($1.4M) of Medicare receipts, signaling reliance on a small set of high-revenue drug/procedure codes.

Payer mix is effectively single‑payer Medicare: the file reports Total Medicare revenue of $3.3M and Total Medicaid revenue: none, so there is no recorded Medicaid billing on file and the provider operates without measurable Medicaid revenue participation. This profile implies limited exposure to Medicaid-rate dynamics and programmatic variation in the state Medicaid market.

Competitive standing is mixed by service type: the provider is an extreme outlier on ophthalmology-specific comprehensive exam volume, with 92014 at 2.5K claims and $258.2K (7.9%) that ranks #132 of 35415 providers nationally (100th percentile; extreme outlier), and likewise shows extreme imaging volume for 92134 (2.4K claims, $84.6K, ranks #709 of 26868, 97th percentile). By contrast, the top anti‑VEGF drug J0178 ranks #518 of 3204 (84th percentile; typical, unremarkable volume), so the practice is regionally/nationally notable for certain high-volume ophthalmology exams and imaging but only typical-to-above-typical for some drug administration volumes.

The practice demonstrates a procedural and ophthalmology‑code centric visit pattern rather than reliance on general E/M codes: 92014 appears 2.5K times while general E/M code 99214 is only 13 claims and 99204 is 157 claims, indicating most encounters are billed under ophthalmology specialty exam codes rather than non‑specialist outpatient E/M codes. This coding mix is consistent with a specialty eye clinic workflow that uses ophthalmology‑specific visit codes as the primary encounter-level billing.

Ancillary imaging and monitoring are substantial elements of throughput: 92134 (computerized retinal imaging) is 2.4K claims and $84.6K (2.6% of Medicare revenue) and ranks #709 of 26868 providers (97th percentile; extreme outlier), supporting that diagnostic imaging is frequently used to guide treatment decisions and follow-up. High volumes of both imaging and injection codes together suggest a retina-focused practice model where imaging drives treatment frequency.

The provider’s drug billing mix includes use of multiple branded, biosimilar, and unclassified biologic codes: beyond J0178 and J2778, material revenue appears under J3590 (106 claims, $245.9K, 7.6%) and J3490 (78 claims, $141.6K, 4.4%), indicating notable line items coded to unclassified biologics and unclassified drugs. This pattern implies recurrent billing for items outside the standard named drug codes and contributes materially to the overall Medicare revenue profile.

NPI tenure signals an established practice footprint: the NPI was enumerated on 2014-03-29 (~12 years ago), indicating the provider has been active under this NPI for roughly a decade-plus, which aligns with the observed sustained volumes across injections, exams, and imaging rather than a short‑term billing spike. This longevity supports interpreting high-volume lines as ongoing service patterns rather than transient activity.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,040	$690	$1.4M
J2778	Injection, ranibizumab, 0.1 mg	1,620	$190	$306.2K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	2,460	$110	$258.2K
J3590	Unclassified biologics	110	$2,320	$245.9K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	1,090	$220	$235.4K
J2777	Injection, faricimab‑svoa, 0.1 mg	8,100	$30	$234.9K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,800	$110	$188.7K
J3490	Unclassified drugs	80	$1,820	$141.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,420	$40	$84.6K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	710	$120	$84.6K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Missouri Distribution

Harris Sultan — 5 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Missouri

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	9	60	820	$690	$683.3K
J2777	28	50	11,730	$30	$388.9K
J2778	4	20	540	$180	$203.8K
Q5128	1	10	940	$220	$153.4K
67028	8	80	600	$90	$69.7K
J2781	2	10	650	$120	$65.4K
J3590	12	30	80	$160	$19K
92014	1	730	120	$80	$18K
J3490	20	80	40	$150	$14K
99214	8,668	8,960	100	$80	$13.9K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with Harris Sultan, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Associated Retinal Consultants LLC	DE	Ophthalmology Physician	$0	$25.2M
Rohit Lakhanpal	MD	Retina Specialist (Ophthalmology) Physician	$6.1M	$0
Vinod Voleti	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Sumit Shah	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Newman Sund	MD	Ophthalmology Physician	$4M	$0
Eric Suan	MD	Ophthalmology Physician	$3.8M	$0
Matthew Speicher	MD	Ophthalmology Physician	$3.7M	$0
Howard Fine	NJ	Retina Specialist (Ophthalmology) Physician	$3.6M	$0
Timothy Polk	MD	Ophthalmology Physician	$3.5M	$0
Jonathan Prenner	NJ	Retina Specialist (Ophthalmology) Physician	$3.4M	$0

Nearby Providers

Other providers in the same ZIP code as Harris Sultan, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Council For Extended Care	MO	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$98.1M
St. Louis Children's Hospital	MO	Children's Hospital	$0	$66.9M
Barnes Jewish Hospital	MO	General Acute Care Hospital	$0	$61.4M
Paraquad Inc	MO	Customized Equipment (DME)	$0	$56.3M
Washington University	MO	Multi-Specialty Clinic/Center	$0	$22M
Cooperative Home Care, Inc.	MO	Home Health Agency	$0	$20.6M
Washington University	MO	Multi-Specialty Clinic/Center	$0	$14.8M
New Beginnings In Home Services, LLC	MO	In Home Supportive Care Agency	$0	$11.6M
Washington University	MO	Multi-Specialty Clinic/Center	$0	$10.4M
Washington University	MO	Emergency Care Clinic/Center	$0	$9.1M

Harris Sultan — Billing Profile & Reimbursement Data

Sign up for Harris Sultan — Billing Profile & Reimbursement Data policy alerts

Harris Sultan — Billing Profile & Reimbursement Data

Sign up for Harris Sultan — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References